1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alghamdi, S; Mendonca, P; Messeha, S; Soliman, KFA | 1 |
| Chen, WJ; Chen, YJ; Huang, C; Huang, HC; Lin, CL; Wei, YX | 1 |
2 other study(ies) available for 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Pentagalloyl glucose inhibits TNF-α-activated CXCL1/GRO-α expression and induces apoptosis-related genes in triple-negative breast cancer cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemokine CXCL1; Cytokines; Gene Expression Regulation, Neoplastic; Humans; Hydrolyzable Tannins; Inflammation; Models, Biological; Neoplasm Proteins; RNA, Messenger; Triple Negative Breast Neoplasms; Tumor Necrosis Factor-alpha | 2021 |
Combined treatment with chrysin and 1,2,3,4,6-penta-O-galloyl-β-D-glucose synergistically inhibits LRP6 and Skp2 activation in triple-negative breast cancer and xenografts.
Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drug Synergism; Female; Flavonoids; Heterografts; Humans; Hydrolyzable Tannins; Low Density Lipoprotein Receptor-Related Protein-6; Mice, Inbred BALB C; Mice, Nude; S-Phase Kinase-Associated Proteins; Triple Negative Breast Neoplasms | 2015 |